Back

Biomarkers in Risk Assessment: Lipids and Beyond.

10 November 2019 (09:20 - 09:35)
Organised by:
Congress Presentation Part of: How to Assess Cardiovascular Risk in Clinical Practice? Cardiovascular Risk Assessment ESC Premium Access ESC Asia with APSC & AFC

About the speaker

Photo
Doctor Alan Fong

Sarawak Heart Center, Kuching (Malaysia)

5 More presentations in this session

Presentation thumbnail
Risk Scores: Advantages and Pitfalls.
Professor S. Gielen (Detmold, DE)
Slides Video
Presentation thumbnail
Discussion - Risk Scores: Advantages and Pitfalls
Presentation thumbnail
Discussion - Biomarkers in Risk Assessment: Lipids and Beyond.
Presentation thumbnail
Imaging – A Must or an Add-on in Risk Assessment?
Professor M. Marwan (Erlangen, DE)
Slides Video
Presentation thumbnail
Discussion - Imaging – A Must or an Add-on in Risk Assessment?

Access the full session

Session thumbnail
How to Assess Cardiovascular Risk in Clinical Practice?

The Event

Event poster

ESC Asia with APSC & AFC

10 November 2019 09:20 CET
You may be interested in
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
17 December 2024
thumbnail
Congress Presentation
Identification of different lipid profiles in patients with zero calcium score with or without plaques after coronary computed tomography: a prospective registry to refine primary prevention
30 August 2025
thumbnail
Congress Presentation
Association between carotid intima-media thickness and novel lipid parameters in hypertensive patients
31 August 2025
thumbnail
Congress Presentation
Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical study of 92 biomarkers
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources